Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.74B | 9.45B | 9.49B | 10.11B | 9.39B | 7.84B |
Gross Profit | 1.79B | 1.73B | 1.65B | 1.95B | 1.94B | 1.39B |
EBITDA | 598.70M | 501.90M | 494.50M | 780.20M | 795.70M | 267.60M |
Net Income | 205.80M | 131.30M | -35.40M | 196.40M | 250.00M | -220.50M |
Balance Sheet | ||||||
Total Assets | 7.56B | 7.55B | 7.77B | 7.95B | 7.89B | 7.34B |
Cash, Cash Equivalents and Short-Term Investments | 618.20M | 793.30M | 767.70M | 644.50M | 770.70M | 1.07B |
Total Debt | 3.24B | 3.31B | 3.57B | 3.60B | 3.66B | 3.68B |
Total Liabilities | 5.65B | 5.79B | 6.10B | 6.29B | 6.44B | 6.24B |
Stockholders Equity | 1.90B | 1.75B | 1.68B | 1.66B | 1.45B | 1.09B |
Cash Flow | ||||||
Free Cash Flow | 126.00M | 167.00M | 101.20M | -1.60M | 495.70M | -79.20M |
Operating Cash Flow | 149.30M | 208.00M | 152.20M | 49.10M | 549.50M | -38.20M |
Investing Cash Flow | 44.90M | 81.20M | 48.90M | -120.70M | -749.50M | -257.80M |
Financing Cash Flow | -154.20M | -253.40M | -120.80M | -79.30M | -65.80M | 571.90M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $14.58B | 26.77 | 8.40% | ― | 13.47% | 47.52% | |
75 Outperform | $3.67B | 18.01 | 11.62% | ― | 4.63% | 887.64% | |
74 Outperform | $48.11B | 46.05 | 13.13% | ― | 14.96% | 19.11% | |
67 Neutral | $1.72B | ― | -12.78% | 1.78% | 3.55% | -36.05% | |
66 Neutral | $3.17B | 40.80 | 6.00% | 0.65% | 16.29% | 69.89% | |
63 Neutral | $7.02B | 13.41 | -0.50% | 6.86% | 4.08% | -25.24% | |
55 Neutral | $1.28B | ― | -1.99% | 1.51% | 17.89% | 65.32% |
On July 21, 2025, Cushman & Wakefield announced the successful repricing of its $948 million Term Loan, initially issued in October 2024 and due in 2030, reducing the interest rate by 50 basis points. This move, alongside a recent $25 million prepayment, reflects the company’s strategy to enhance its capital structure by focusing on debt reduction and disciplined growth.
On June 19, 2025, Brett White announced his resignation from the board of Cushman & Wakefield, effective July 31, 2025, after over a decade of service. He will transition to a strategic consultant role until February 28, 2026. White’s leadership was pivotal in the company’s growth, including its IPO and strategic investments. The board has appointed Susan Daimler, Timothy Wennes, and Stephen D. Plavin as new directors, with Plavin becoming the Chairman on October 1, 2025. These appointments align with the company’s strategic focus on growth and innovation, enhancing its capabilities in commercial real estate and technology.